Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

RenJi Hospital

17 clinical trials · 17 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by RenJi Hospital

RECRUITINGNCT06306612

CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

The goal of this clinical trial is to compare systemic therapy combined with cytoreductive prostatectomy with standard of care (SOC) in de novo poly-metastatic hormone sensitive...

Sponsor: RenJi HospitalEnrolling: 1921 location
Prostate Cancer
RECRUITINGNCT06362577

Clinical Study of HIFU for Localized Prostate Cancer

In this study, the safety and effectiveness data of Sonablate system, a transrectal high-intensity focused ultrasound therapeutic instrument, in the treatment of localized...

Sponsor: RenJi HospitalEnrolling: 601 location
Localized Prostate Cancer
RECRUITINGNCT06715839

Target-specific immunoPET Imaging of Digestive System Carcinoma

The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of...

Sponsor: RenJi HospitalEnrolling: 4001 location
MalignancyDigestive CancerDigestive System Neoplasm+12
RECRUITINGNCT06519578

Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

This study is a prospective cohort study aimed at comparing the efficacy and safety of RALOX-HAIC and FOLFOX-HAIC in the treatment of hepatocellular carcinoma. It is planned to...

Sponsor: RenJi HospitalEnrolling: 11152 locations
Hepatocellular Carcinoma
RECRUITINGNCT06519721

Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC

This study is a single-arm, open-label trial to clarify the safety and efficacy of the combined treatment of lenvatinib and VIC-1911 in patients with advanced liver cancer.

Sponsor: RenJi HospitalEnrolling: 151 location
Hepatocellular Carcinoma
RECRUITINGNCT06852638

CD70-targeted immunoPET Imaging of Malignant Cancers

This study aims to establish and optimize the cluster of differentiation (CD70)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging method and...

Sponsor: RenJi HospitalEnrolling: 3001 location
Renal CancerRenal Clear Cell CarcinomaLymphoma+4
RECRUITINGPhase 2NCT06680089

CD70-targeted immunoPET Imaging of Kidney Cancer

The aim of this study is to establish and optimize the \[18F\]RCCB6 PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of...

Sponsor: RenJi HospitalEnrolling: 3001 location
Urologic NeoplasmsUrogenital NeoplasmsKidney Neoplasms+1
RECRUITINGPhase 2NCT05957757

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

This is a prospective, open, single-center clinical study of anti-HER2-ADC combined with PD-1 monoclonal antibody for bladder sparing treatment in non-muscular invasive bladder...

Sponsor: RenJi HospitalEnrolling: 201 location
Non-Muscle Invasive Bladder CancerHER2
RECRUITINGPhase 2NCT06091124

Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma

The goal of this clinical trial is to learn about the efficacy and safety of neoadjuvant adebrelimab plus etoposide and cisplatin in patients with neuroendocrine bladder...

Sponsor: RenJi HospitalEnrolling: 225 locations
Neuroendocrine Carcinoma of the BladderBladder Cancer
RECRUITINGPhase 1NCT06249438

A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

This is an investigator-initiated, multicenter, open-label study of C-CAR168, an autologous bi-specific CAR-T therapy targeting CD20 and BCMA, for the treatment of adult patients...

Sponsor: RenJi HospitalEnrolling: 301 location
Systemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)+3
RECRUITINGNCT07149935

Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients

This multicenter, open label, double-arm study aims at investigating the the continuous effect of long-Term rehabilitation training on clinical improvement(ITTCI) and...

Sponsor: RenJi HospitalEnrolling: 1041 location
Pulmonary Hypertension
RECRUITINGNCT06385834

The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients...

The aim of the study was to intervene in the Aerobic exercise time of patients with STEMI and to explore the optimal exercise time for STEMI patients

Sponsor: RenJi HospitalEnrolling: 2011 location
ST-segment Elevation Myocardial Infarction (STEMI)
RECRUITINGNCT05286710

Rheolytic Thrombectomy For Acute Deep Vein Thrombosis Of Whole Lower Limb

Ipsilateral popliteal venous the most common access for pharmacomechanical thrombectomy (PMT) in the treatment of acute deep venous thrombosis (DVT), but the result was not...

Sponsor: RenJi HospitalEnrolling: 1601 location
Deep Vein Thrombosis
RECRUITINGNCT06124768

Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis

The study aims to compare the modified approach through ipsilateral deep calf venous access or contralateral femoral venous access with the traditional approach through...

Sponsor: RenJi HospitalEnrolling: 2101 location
Deep Vein Thrombosis
RECRUITINGNCT06394063

Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients

This study is a randomized, double-blind, placebo-controlled single-center clinical trial. The aim of this study is to investigate the efficacy and safety of low-dose telitacicept...

Sponsor: RenJi HospitalEnrolling: 1761 location
Systemic Lupus Erythematosus
RECRUITINGPhase 1NCT06316076

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

To evaluate the safety and efficacy of CD19-CAR-DNT cells in subjects with relapsed/refractory autoimmune diseases

Sponsor: RenJi HospitalEnrolling: 481 location
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisIdiopathic Inflammatory Myopathies+1
RECRUITINGNCT06391320

Obesity Queue Database

To establish an obesity specific disease cohort database and form a special disease cohort, so as to provide guarantee for carrying out high-quality real-world clinical research...

Sponsor: RenJi HospitalEnrolling: 50001 location
Obesity